Tenaya Therapeutics IPO

Tenaya Therapeutics is a biopharmaceutical company focused on addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.

Register for Details

For more details on financing and valuation for Tenaya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Tenaya Therapeutics's ticker symbol?


What is Tenaya Therapeutics's stock price?

2.56 as of 3/23/23

Learn more about Tenaya Therapeutics

Forge green plus iconForge green minus icon

What is Tenaya Therapeutics funding to date?

Tenaya Therapeutics has raised $142MM.
Forge green plus iconForge green minus icon

When was Tenaya Therapeutics founded?

Tenaya Therapeutics was founded in 2016.